beta glucosylceramide
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2006 (NCT02126306)
Timeline
Indications
Mechanism of action
- Beta-glucocerebrosidaseACTIVATOR
GBA activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- beta-d glucosylceramide
- beta glucosylceramide
- β-d glucosylceramide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01646736 | Phase 2/Phase 3 (Phase 3) | Jul 1, 2012 | Tsinghua University |
| NCT00619372 | Phase 1 | Jan 1, 2008 | Hebrew University |
| NCT02126306 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2006 | Hebrew University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hebrew University | Academic/Hospital | 2 | 2 | 2 | 2006 |
| Tsinghua University | Academic/Hospital | 1 | 1 | 1 | 2012 |
2 organizations
Page 1 / 1